DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2316456
Country | SPC | SPC Expiration |
---|---|---|
Germany | 122017000109 | ➤ Sign Up |
Netherlands | 300918 | ➤ Sign Up |
Denmark | CA 2017 00062 | ➤ Sign Up |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2316456
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jul 20, 2024 | Orexigen | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
➤ Sign Up | Mar 26, 2025 | Orexigen | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |